Article
SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer
1 Jan 2016
Abstract excerpt
BACKGROUND: SOX17 belongs to the high-mobility group-box transcription factor superfamily and down-regulates the Wnt pathway. The aim of our study was to evaluate the prognostic significance of SOX17 promoter methylation in circulating tumor DNA (ctDNA) in plasma of non-small cell lung cancer (NSCLC) patients. METHODS: We examined the methylation status of SOX17 promoter in 57 operable NSCLC primary tumors and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
